Kovacs Shane William Charles 4
4 · Olema Pharmaceuticals, Inc. · Filed Nov 18, 2024
Insider Transaction Report
Form 4
Kovacs Shane William Charles
CH. OPERATING & FINANCIAL OFF.
Transactions
- Exercise/Conversion
Stock Option (Right to Buy)
2024-11-15−25,000→ 162,000 totalExercise: $7.02Exp: 2032-01-31→ Common Stock (25,000 underlying) - Exercise/Conversion
Common Stock
2024-11-15$7.02/sh+25,000$175,500→ 510,458 total
Footnotes (2)
- [F1]Includes 471 shares acquired under the issuer's Employee Stock Purchase Plan on June 28, 2024.
- [F2]25% of the shares subject to the option vested on February 1, 2023 and 1/48 of the total number of shares subject to the option vest each month thereafter, subject to the Reporting Person's continuous service through each applicable vesting date.